Document is current

Any future updates will be listed below

Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase

Crossref DOI link: https://doi.org/10.1186/s13058-014-0430-x

Published Online: 2014-09-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark